Clinical Trial

The Effectiveness of Virtual Reality Training Program

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 30, 2024 (before its estimated August 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Alzheimer's disease is the most common type of dementia, accounting for 50% of all cases. Advanced age is a significant risk factor for AD. Virtual Reality (VR) is an interactive video game technology that provides computer-generated environments that include physical activity and provide users with experiences similar to those in the real world. VR technology can be used for rehabilitation purposes in individuals with various orthopedic and neurological disorders due to its ability to enhance motor, cognitive learning and neural plasticity (1,2). The aim of our study was to examine the effect of the Virtual Reality Training Program on cognition in individuals with Alzheimer's disease living in the community.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-26.
Trial Details
NCT Number NCT06575218
Lead Sponsor Yeditepe University
Conditions Alzheimer Disease
Enrollment 45 participants
Start Date 2024-05-21
Primary Completion 2024-08-31 (estimated)
Study Completion 2024-09-06 (estimated)
Updated on ClinicalTrials.gov 2024-08-30